PAG
CSCI

Private Advisor Group’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Private Advisor Group’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-205
Closed -$42K – 1429
2017
Q3 		$42K Buy
+205
New +$37.7K ﹤0.01% 1445

Other funds holding CSCI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Private Advisor Group's CSCI Position: Q4 2017 in Review

Private Advisor Group sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q4 2017, closing a stake of 205 shares — an estimated $42K sold.

Private Advisor Group first reported a position in CSCI in Q3 2017 and held it in 1 quarter. The position peaked at $42K in Q3 2017. 15 funds tracked by Wall St. Rank hold CSCI as of Q4 2017.

  • Private Advisor Group reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Private Advisor Group sold 205 COSCIENS Biopharma Inc. Common Stock shares in Q4 2017, an estimated $42K.
  • Private Advisor Group first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2017 and held it in 1 quarter.
  • Private Advisor Group's COSCIENS Biopharma Inc. Common Stock position peaked at $42K in Q3 2017.
  • 15 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q4 2017.

Based on Private Advisor Group's 13F filing for Q4 2017, filed 7 Feb 2018.